Natixis Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$122M Buy
434,693
+33,517
+8% +$8.81M 0.14% 147
2026
Q1
$107M Buy
401,176
+36,789
+10% +$9.96M 0.15% 148
2025
Q4
$91.4M Sell
364,387
-17,779
-5% -$4.72M 0.13% 167
2025
Q3
$110M Sell
382,166
-116,889
-23% -$31.3M 0.16% 140
2025
Q2
$131M Buy
499,055
+148,122
+42% +$36.1M 0.21% 110
2025
Q1
$81.7M Buy
350,933
+30,781
+10% +$7.47M 0.15% 150
2024
Q4
$73.4M Buy
320,152
+28,229
+10% +$6.48M 0.14% 155
2024
Q3
$65.2M Buy
291,923
+42,999
+17% +$9.45M 0.13% 165
2024
Q2
$50.7M Buy
248,924
+72,611
+41% +$14.8M 0.11% 187
2024
Q1
$38.5M Buy
176,313
+47,849
+37% +$10.5M 0.09% 234
2023
Q4
$29.2M Sell
128,464
-42,645
-25% -$8.96M 0.08% 269
2023
Q3
$34.4M Sell
171,109
-7,766
-4% -$1.64M 0.11% 215
2023
Q2
$31.9M Buy
178,875
+38,187
+27% +$7.41M 0.1% 219
2023
Q1
$27.7M Sell
140,688
-15,751
-10% -$3.24M 0.1% 234
2022
Q4
$31.6M Buy
156,439
+32,738
+26% +$6.4M 0.12% 207
2022
Q3
$21.8M Buy
123,701
+43,931
+55% +$8.99M 0.09% 252
2022
Q2
$16.1M Sell
79,770
-5,260
-6% -$1.12M 0.07% 327
2022
Q1
$19.3M Buy
85,030
+30,494
+56% +$7.17M 0.07% 298
2021
Q4
$14.7M Sell
54,536
-6,498
-11% -$1.61M 0.06% 354
2021
Q3
$14.8M Sell
61,034
-9,287
-13% -$2.34M 0.06% 323
2021
Q2
$16.7M Buy
70,321
+2,511
+4% +$572K 0.08% 288
2021
Q1
$14.9M Sell
67,810
-561
-0.8% -$113K 0.08% 293
2020
Q4
$12M Buy
68,371
+1,138
+2% +$197K 0.07% 316
2020
Q3
$10.9M Sell
67,233
-796
-1% -$126K 0.07% 304
2020
Q2
$9.71M Buy
68,029
+9,263
+16% +$1.28M 0.06% 320
2020
Q1
$6.38M Buy
58,766
+17,707
+43% +$2.55M 0.05% 378
2019
Q4
$5.97M Buy
41,059
+1,688
+4% +$244K 0.04% 470
2019
Q3
$5.68M Buy
39,371
+2,671
+7% +$390K 0.05% 438
2019
Q2
$5.45M Buy
36,700
+1,792
+5% +$250K 0.04% 433
2019
Q1
$4.59M Buy
34,908
+6,847
+24% +$843K 0.04% 474
2018
Q4
$3.05M Sell
28,061
-7,190
-20% -$963K 0.03% 557
2018
Q3
$5.26M Buy
35,251
+2,332
+7% +$355K 0.05% 443
2018
Q2
$5.08M Buy
32,919
+4,166
+14% +$629K 0.05% 449
2018
Q1
$4M Buy
28,753
+1,908
+7% +$280K 0.04% 512
2017
Q4
$3.68M Buy
26,845
+1,832
+7% +$242K 0.04% 514
2017
Q3
$3.24M Buy
25,013
+517
+2% +$69K 0.03% 570
2017
Q2
$3.24M Buy
24,496
+3,333
+16% +$408K 0.04% 572
2017
Q1
$2.61M Buy
21,163
+1,693
+9% +$200K 0.03% 630
2016
Q4
$2.15M Sell
19,470
-1,664
-8% -$185K 0.03% 654
2016
Q3
$2.5M Buy
21,134
+1,062
+5% +$125K 0.03% 597
2016
Q2
$2.25M Buy
20,072
+5,438
+37% +$585K 0.03% 598
2016
Q1
$1.47M Sell
14,634
-1
-0% -$96 0.02% 697
2015
Q4
$1.55M Buy
14,635
+580
+4% +$59.8K 0.03% 663
2015
Q3
$1.31M Buy
14,055
+1,422
+11% +$147K 0.02% 713
2015
Q2
$1.32M Sell
12,633
-184
-1% -$19.2K 0.02% 721
2015
Q1
$1.39M Buy
12,817
+856
+7% +$88K 0.02% 714
2014
Q4
$1.11M Sell
11,961
-365
-3% -$32.2K 0.02% 766
2014
Q3
$1.08M Buy
12,326
+1,245
+11% +$112K 0.02% 757
2014
Q2
$975K Buy
11,081
+2,435
+28% +$211K 0.01% 824
2014
Q1
$730K Buy
8,646
+2,287
+36% +$182K 0.01% 848
2013
Q4
$499K Sell
6,359
-843
-12% -$71.9K 0.01% 894
2013
Q3
$614K Buy
7,202
+748
+12% +$63K 0.01% 794
2013
Q2
$555K Buy
+6,454
New +$536K 0.01% 794

Other funds holding LH

Natixis Advisors's LH Position: Q2 2026 in Review

Natixis Advisors increased its Labcorp (LH) stake by 8.4% in Q2 2026, buying an estimated $8.81M and bringing the position to 434,693 shares worth $122M. The position accounts for 0.14% of the portfolio, ranked #147.

Natixis Advisors first reported a position in LH in Q2 2013 and has held it in 53 quarters since. The position peaked at $131M in Q2 2025. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Natixis Advisors held 434,693 shares of Labcorp worth $122M as of Q2 2026.
  • Natixis Advisors bought 33,517 Labcorp shares in Q2 2026, an estimated $8.81M.
  • Labcorp made up 0.14% of Natixis Advisors's portfolio in Q2 2026, its #147 holding.
  • Natixis Advisors first reported a position in Labcorp in Q2 2013 and has held it in 53 quarters since.
  • Natixis Advisors's Labcorp position peaked at $131M in Q2 2025.
  • 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.